Produces titanium dioxide (TiO2) pigments for coatings, plastics, and paper. Offers refrigerants and thermal management solutions. Now — the numbers.
Revenue is spread across several lines; no single product carries the company.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 0.4× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 35% of them.
Analysts' average target sits 46% above today's price.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
An investor who bought at the very peak is down 66% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The company sells $5.8B a year; the problem isn’t sales — it’s costs running above that number.
Over the last 12 months, company executives reported 31 buys and 14 sells. Management buying with its own money is usually read as a good sign.
It pays out $0.35 per share each year — regular cash for whoever holds the stock.
A loss of $386M against $5.8B in annual sales.
At the current pace of spending, the cash lasts about 1.7 years. After that, the company needs to find new money.
On our five-subject report card, CC sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CC’s sales are going backwards, and it closed last year at a loss. The road back runs through both.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (35/100) says the stock isn’t cheap.